Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

[Outpatient specialist medical treatment (ASV)-a new treatment level in rheumatology].

Edelmann E, Lakomek HJ, Bessler F, Braun J, Froschauer S, Hellmich B, von Hinüber U, Kalthoff L, Karberg K, Kekow J, Krause A, Müller-Brodmann W, Munte A, Ruehlmann JM, Zinke S.

Z Rheumatol. 2019 Oct;78(8):765-773. doi: 10.1007/s00393-019-0685-9. Review. German.

PMID:
31456005
2.

Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma.

Pertl U, Wodrich H, Ruehlmann JM, Gillies SD, Lode HN, Reisfeld RA.

Blood. 2003 Jan 15;101(2):649-54. Epub 2002 Sep 12.

PMID:
12393580
3.

MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma.

Ruehlmann JM, Xiang R, Niethammer AG, Ba Y, Pertl U, Dolman CS, Gillies SD, Reisfeld RA.

Cancer Res. 2001 Dec 1;61(23):8498-503.

4.

An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice.

Niethammer AG, Primus FJ, Xiang R, Dolman CS, Ruehlmann JM, Ba Y, Gillies SD, Reisfeld RA.

Vaccine. 2001 Nov 12;20(3-4):421-9.

PMID:
11672905
5.

A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice.

Xiang R, Primus FJ, Ruehlmann JM, Niethammer AG, Silletti S, Lode HN, Dolman CS, Gillies SD, Reisfeld RA.

J Immunol. 2001 Oct 15;167(8):4560-5.

6.

Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma.

Niethammer AG, Xiang R, Ruehlmann JM, Lode HN, Dolman CS, Gillies SD, Reisfeld RA.

Cancer Res. 2001 Aug 15;61(16):6178-84.

7.

Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice.

Xiang R, Silletti S, Lode HN, Dolman CS, Ruehlmann JM, Niethammer AG, Pertl U, Gillies SD, Primus FJ, Reisfeld RA.

Clin Cancer Res. 2001 Mar;7(3 Suppl):856s-864s.

PMID:
11300483
8.

An autologous oral DNA vaccine protects against murine melanoma.

Xiang R, Lode HN, Chao TH, Ruehlmann JM, Dolman CS, Rodriguez F, Whitton JL, Overwijk WW, Restifo NP, Reisfeld RA.

Proc Natl Acad Sci U S A. 2000 May 9;97(10):5492-7.

Supplemental Content

Loading ...
Support Center